
FIGS, Inc. (NYSE:FIGS – Free Report) – Stock analysts at KeyCorp issued their Q1 2026 earnings per share (EPS) estimates for FIGS in a research report issued on Friday, February 27th. KeyCorp analyst A. Owens forecasts that the company will earn $0.01 per share for the quarter. KeyCorp has a “Overweight” rating and a $17.00 price objective on the stock. The consensus estimate for FIGS’s current full-year earnings is $0.01 per share. KeyCorp also issued estimates for FIGS’s Q2 2026 earnings at $0.07 EPS and Q3 2026 earnings at $0.07 EPS.
FIGS (NYSE:FIGS – Get Free Report) last posted its quarterly earnings results on Thursday, February 26th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.08. FIGS had a return on equity of 8.41% and a net margin of 5.43%.The company had revenue of $201.90 million during the quarter, compared to analysts’ expectations of $165.33 million. During the same quarter in the previous year, the firm earned $0.01 EPS. FIGS’s revenue was up 33.0% on a year-over-year basis.
View Our Latest Stock Analysis on FIGS
FIGS Stock Up 23.8%
FIGS stock opened at $15.44 on Monday. The stock has a market cap of $2.54 billion, a PE ratio of 81.24 and a beta of 1.21. FIGS has a 12-month low of $3.57 and a 12-month high of $15.90. The business’s 50-day moving average price is $11.39 and its two-hundred day moving average price is $9.39.
Insider Buying and Selling at FIGS
In other FIGS news, insider Heather L. Hasson sold 22,874 shares of the company’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $10.56, for a total value of $241,549.44. Following the completion of the transaction, the insider directly owned 1,251,967 shares in the company, valued at approximately $13,220,771.52. This represents a 1.79% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Catherine Eva Spear sold 49,734 shares of FIGS stock in a transaction on Tuesday, January 6th. The stock was sold at an average price of $11.38, for a total transaction of $565,972.92. Following the transaction, the chief executive officer owned 1,857,299 shares in the company, valued at approximately $21,136,062.62. This trade represents a 2.61% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 105,813 shares of company stock worth $1,168,051. 29.44% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On FIGS
Institutional investors have recently made changes to their positions in the stock. Marshall Wace LLP increased its stake in shares of FIGS by 66.2% in the fourth quarter. Marshall Wace LLP now owns 4,297,868 shares of the company’s stock valued at $48,824,000 after buying an additional 1,712,610 shares during the period. Bamco Inc. NY lifted its holdings in FIGS by 2.2% in the second quarter. Bamco Inc. NY now owns 59,974,407 shares of the company’s stock valued at $338,256,000 after buying an additional 1,302,823 shares during the period. BNP Paribas Financial Markets boosted its position in FIGS by 2,139.7% during the second quarter. BNP Paribas Financial Markets now owns 1,307,468 shares of the company’s stock valued at $7,374,000 after acquiring an additional 1,249,091 shares during the last quarter. Ameriprise Financial Inc. boosted its position in shares of FIGS by 9.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 13,936,468 shares of the company’s stock valued at $78,602,000 after purchasing an additional 1,144,962 shares in the last quarter. Finally, Squarepoint Ops LLC grew its position in shares of FIGS by 940.7% during the 2nd quarter. Squarepoint Ops LLC now owns 924,092 shares of the company’s stock worth $5,212,000 after buying an additional 835,300 shares during the period. Institutional investors own 92.21% of the company’s stock.
Key Headlines Impacting FIGS
Here are the key news stories impacting FIGS this week:
- Positive Sentiment: Q4 earnings beat — FIGS reported $0.10 EPS vs. $0.02 consensus and revenue of $201.9M (up 33% YoY), signaling solid top-line momentum and margin expansion. Article Title
- Positive Sentiment: Aggressive FY2026 revenue guide — management is targeting roughly $694M–$707M (around a $700M target cited publicly), well above Street consensus (~$625.6M), and flagged international expansion and margin improvement as priorities. That guidance materially raises growth expectations. Article Title
- Positive Sentiment: Analyst upgrade — KeyCorp moved FIGS from sector weight to overweight with a $17 price target, providing third‑party validation of the company’s growth trajectory. Article Title
- Neutral Sentiment: Telsey raised its price target from $9 to $15 and set a “market perform” rating — upgrade in target, but PT sits slightly below the current share price. Article Title
- Neutral Sentiment: BTIG reaffirmed a “buy” rating with a $15 target — keeps buy conviction but target is not above the current price, limiting near-term upside from that shop. Article Title
- Neutral Sentiment: Conference call and analyst write-ups published — transcripts and call highlights provide detail on Olympic partnership, international rollout and margin levers for investors doing deeper diligence. Article Title
- Negative Sentiment: Valuation and mixed price-targets risk — FIGS trades with a high P/E and recently hit a 12‑month high, leaving shares vulnerable to profit-taking; several widely cited targets (~$15) sit at or below the current price. Article Title
FIGS Company Profile
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
See Also
- Five stocks we like better than FIGS
- America’s 1776 happening again
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- This makes me furious
- Elon Musk: This Could Turn $100 into $100,000
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.
